Skip to main content
logo
Vivoryon Therapeutics N.V. (FRA:05Y)
Germany flag Germany · Delayed Price · Currency is EUR
1.498
-0.012 (-0.79%)
At close: Jan 30, 2026

Vivoryon Therapeutics Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
---3.62-10.76-
Cost of Revenue
---0.53-1.57-
Gross Profit
---3.1-9.2-
Selling, General & Admin
6.166.98.68.914.552.81
Research & Development
6.5214.0617.6420.2217.4513.21
Other Operating Expenses
---0.5-0.02-0.01-0.01
Operating Expenses
12.6820.9625.7429.1121.9916.01
Operating Income
-12.68-20.96-28.84-29.11-12.8-16.01
Interest Expense
-0.05-0.05-0.06-0.02-0.02-
Interest & Investment Income
0.240.430.480.040.020.03
Currency Exchange Gain (Loss)
0.010.02-0.20.690.75-0.48
Other Non Operating Income (Expenses)
---0.05-0.1-0.02
EBT Excluding Unusual Items
-12.48-20.57-28.62-28.35-12.15-16.48
Gain (Loss) on Sale of Investments
--0.04-0.01-0.08-0.03
Gain (Loss) on Sale of Assets
-0-0----
Pretax Income
-12.48-20.57-28.58-28.36-12.22-16.51
Income Tax Expense
---0.23-0.20.43-
Net Income
-12.48-20.57-28.34-28.16-12.66-16.51
Net Income to Common
-12.48-20.57-28.34-28.16-12.66-16.51
Shares Outstanding (Basic)
262625222020
Shares Outstanding (Diluted)
262625222020
Shares Change (YoY)
3.18%3.27%14.64%10.10%0.12%59.17%
EPS (Basic)
-0.48-0.79-1.12-1.28-0.63-0.83
EPS (Diluted)
-0.48-0.79-1.12-1.28-0.63-0.83
Free Cash Flow
-10.38-19.18-21.56-21.81-11.28-14.08
Free Cash Flow Per Share
-0.40-0.74-0.85-0.99-0.56-0.70
Gross Margin
----85.42%-
Operating Margin
-----118.91%-
Profit Margin
-----117.57%-
Free Cash Flow Margin
-----104.77%-
EBITDA
-12.59-20.87-28.76-29.04-12.73-15.96
EBITDA Margin
-----118.22%-
D&A For EBITDA
0.090.090.080.070.070.05
EBIT
-12.68-20.96-28.84-29.11-12.8-16.01
EBIT Margin
-----118.91%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.